Non-U.S. operators of the M60 Patton

Verano Announces Third Quarter 2023 Financial Results

Retrieved on: 
Wednesday, November 8, 2023

CHICAGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (NEO: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the third quarter ended September 30, 2023, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

Key Points: 
  • Revenue for the third quarter 2023 was $240 million, up 5% from $228 million for the third quarter 2022, and up 3% from $234 million for the second quarter 2023.
  • Gross profit for the third quarter 2023 was $133 million or 55% of revenue, up from $123 million or 54% of revenue for the third quarter 2022, and up from $115 million or 49% of revenue for the second quarter 2023.
  • SG&A expense for the third quarter 2023 was $86 million or 36% of revenue, flat with $86 million or 38% of revenue for the third quarter 2022, and up from $85 million or 36% of revenue for the second quarter 2023.
  • Net loss for the third quarter 2023 was $(18) million, versus a loss of $(43) million in the third quarter 2022, and $(13) million for the second quarter 2023.

In-Space Manufacturing Leader Space Forge Appoints New Director of Strategy and Innovation

Retrieved on: 
Wednesday, November 8, 2023

WASHINGTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Space Forge, the UK-based leader for in-space manufacturing, announced today a significant addition to its U.S. leadership team with the appointment of Michelle Flemming as Director of Strategy and Innovation.

Key Points: 
  • WASHINGTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Space Forge, the UK-based leader for in-space manufacturing, announced today a significant addition to its U.S. leadership team with the appointment of Michelle Flemming as Director of Strategy and Innovation.
  • The company has been rapidly expanding its global footprint and in June announced industry leader Andrew Parlock as Director of U.S. Operations.
  • Having participated in over 250 parabolic flight missions, her hands-on understanding of microgravity environments provides Space Forge with a unique advantage for its in-space manufacturing initiatives.
  • For more information about Space Forge and its mission, please visit Space Forge's official website.

SEE Reports Q3 2023 Results

Retrieved on: 
Thursday, November 2, 2023

SEE (NYSE: SEE) announced financial results for Q3 2023.

Key Points: 
  • SEE (NYSE: SEE) announced financial results for Q3 2023.
  • I am excited to partner with Emile as we continue to build a culture of execution and accountability.”
    Unless otherwise stated, all results compare third quarter 2023 to third quarter 2022 results from continuing operations.
  • Excluding full year 2023 payments related to the IRS settlement, the Company continues to expect Free Cash Flow in 2023 in the range of $325 to $375 million.
  • SEE will host a conference call and webcast on Thursday, November 2, 2023 at 10:00 a.m. (ET) to discuss our Third Quarter 2023 Results.

UPS Asks Job-Seekers to ‘Picture Yourself in UPS Brown’

Retrieved on: 
Wednesday, November 1, 2023

UPS (NYSE: UPS) announced today it plans to hire at least 60,000 of the 100,000 seasonal employees it needs for the holiday season during one weekend.

Key Points: 
  • UPS (NYSE: UPS) announced today it plans to hire at least 60,000 of the 100,000 seasonal employees it needs for the holiday season during one weekend.
  • This Friday and Saturday, the company’s annual UPS Brown Friday events will take place across the country.
  • Marking six years of UPS Brown Fridays, the hiring blitz begins Nov. 3, with more than 600 in-person and virtual events scheduled nationwide .
  • To learn more about UPS’s referral program or if you’re a UPS employee looking to refer friends and family for UPS jobs, visit ups.loop.jobs .

Fortis Inc. Releases Third Quarter 2023 Results

Retrieved on: 
Friday, October 27, 2023

ST. JOHN'S, Newfoundland and Labrador, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS), a well-diversified leader in the North American regulated electric and gas utility industry, released its third quarter results1.

Key Points: 
  • In August 2023, FortisBC Energy commenced construction of the Eagle Mountain Woodfibre Gas Line project.
  • In October 2023, TEP announced the Roadrunner Reserve project, the largest battery energy storage system in TEP's portfolio.
  • The ROE for 2024 is expected to be determined in the fourth quarter of 2023, with updates annually thereafter.
  • Fortis presents these non-U.S. GAAP measures because management and external stakeholders use them in evaluating the Corporation's financial performance and prospects.

STMicroelectronics Reports 2023 Third Quarter Financial Results

Retrieved on: 
Thursday, October 26, 2023

Inventory at the end of the third quarter was $2.87 billion, compared to $2.38 billion in the year-ago quarter.

Key Points: 
  • Inventory at the end of the third quarter was $2.87 billion, compared to $2.38 billion in the year-ago quarter.
  • Days sales of inventory at quarter-end was 114 days compared to 126 days in the previous quarter and 96 days in the year-ago quarter.
  • ST’s net financial position (non-U.S. GAAP) was $2.46 billion as of September 30, 2023, compared to $1.91 billion as of July 1, 2023 and reflected total liquidity of $5.05 billion and total financial debt of $2.59 billion.
  • ST will conduct a conference call with analysts, investors and reporters to discuss its third quarter 2023 financial results and current business outlook today at 9:30 a.m. Central European Time (CET) / 3:30 a.m. U.S. Eastern Time (ET).

Glooko Appoints Enrique Conterno, former Eli Lilly & Company Senior Executive, to Board of Directors

Retrieved on: 
Wednesday, October 25, 2023

Mr. Conterno is a well-known executive in the pharmaceutical industry with deep expertise in the diabetes field.

Key Points: 
  • Mr. Conterno is a well-known executive in the pharmaceutical industry with deep expertise in the diabetes field.
  • He joins the board of Glooko having served most recently as the Chief Executive Officer and a member of the Board at FibroGen, Inc. Before FibroGen, Mr. Conterno was Senior Vice President for Eli Lilly and Company, serving as President of Lilly USA from January 2017, and President of Lilly Diabetes from 2009, until his retirement from Lilly in December 2019.
  • "Glooko brings innovative digital health solutions to patients, providers, and clinical and pharmaceutical companies around the world.
  • I am excited to leverage my insights to help Glooko to reach its full potential."

VCA Announces Aaron Frazier as New Chief Operating Officer

Retrieved on: 
Thursday, October 12, 2023

LOS ANGELES, Oct. 12, 2023 /PRNewswire/ -- VCA Animal Hospitals, a part of Mars Veterinary Health, announced today it has appointed Aaron Frazier to Chief Operating Officer (COO), promoting him from his most recent role as General Manager (GM) for VCA Canada.

Key Points: 
  • LOS ANGELES, Oct. 12, 2023 /PRNewswire/ -- VCA Animal Hospitals, a part of Mars Veterinary Health, announced today it has appointed Aaron Frazier to Chief Operating Officer (COO), promoting him from his most recent role as General Manager (GM) for VCA Canada.
  • In this role, Aaron reports to Todd Lavender, DVM, President of VCA Animal Hospitals and continues to be a part of the Senior Leadership Team.
  • As COO, Aaron maintains responsibility for VCA Canada and leads VCA's U.S. Operations, which include the West, Central and Eastern Divisions, Urgent Care and Innovation.
  • "I'm incredibly honored and grateful to have this opportunity to help lead VCA forward," said Aaron.

NRMP Establishes Standardized Applicant Placement Rate Metrics for the Main Residency Match® and SOAP®

Retrieved on: 
Wednesday, October 11, 2023

WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) announced today new reporting for the overall placement rate of participants in the Main Residency Match and the Supplemental Offer and Acceptance Program® (SOAP). The NRMP has released a whitepaper, Applicant Placement Rate in the Main Residency Match and Supplemental Offer and Acceptance Program, which reports for the first time both Match and overall placement data for all applicants compared to those who submitted certified rank order lists of programs in the Match. This new placement data offers unprecedented insights into the transition to residency process.

Key Points: 
  • New whitepaper explores the applicant Match Rate vs. Placement Rates
    WASHINGTON, Oct. 11, 2023 /PRNewswire/ -- The National Resident Matching Program® (NRMP®) announced today new reporting for the overall placement rate of participants in the Main Residency Match and the Supplemental Offer and Acceptance Program® (SOAP).
  • At the conclusion of each Main Residency Match cycle, the NRMP has historically reported the applicant Match Rate.
  • To better understand the overall placement rate of Match participants, the NRMP will conduct an additional 10-year historical analysis of the Match Rate and Placement Rates.
  • By releasing both the Match Rate and Placement Rates, the NRMP has established a standardized calculation and definition of applicant placement data, incorporating the multiple variables associated with Match applicants."

EQS-News: Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.

Retrieved on: 
Monday, September 25, 2023

Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.

Key Points: 
  • Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer and Tom Roberts as President and General Manager U.S.
  • Prior to joining Rentschler Biopharma, Mr. von Braunmuehl served as CEO of HMNC Brain Health in Munich, Germany, where he transformed a research-focused organization to a clinical-stage biopharma company.
  • Prof. Dr. Nikolaus F. Rentschler, Chairman of the Supervisory Board of Rentschler Biopharma SE, said: “I would like to warmly welcome Benedikt von Braunmuehl to Rentschler Biopharma.
  • Mr. von Braunmuehl is the perfect fit for leading Rentschler Biopharma, to continue transforming innovative ideas into life-saving biopharmaceuticals in the future.